252 related articles for article (PubMed ID: 12040046)
1. Peroxynitrite inactivates the human dopamine transporter by modification of cysteine 342: potential mechanism of neurotoxicity in dopamine neurons.
Park SU; Ferrer JV; Javitch JA; Kuhn DM
J Neurosci; 2002 Jun; 22(11):4399-405. PubMed ID: 12040046
[TBL] [Abstract][Full Text] [Related]
2. Trypsin disrupts the trafficking of the human dopamine transporter by alpha-synuclein and its A30P mutant.
Wersinger C; Vernier P; Sidhu A
Biochemistry; 2004 Feb; 43(5):1242-53. PubMed ID: 14756560
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide donors inhibit 5-hydroxytryptamine (5-HT) uptake by the human 5-HT transporter (SERT).
Bryan-Lluka LJ; Papacostas MH; Paczkowski FA; Wanstall JC
Br J Pharmacol; 2004 Sep; 143(1):63-70. PubMed ID: 15302679
[TBL] [Abstract][Full Text] [Related]
4. PI 3-kinase regulation of dopamine uptake.
Carvelli L; Morón JA; Kahlig KM; Ferrer JV; Sen N; Lechleiter JD; Leeb-Lundberg LM; Merrill G; Lafer EM; Ballou LM; Shippenberg TS; Javitch JA; Lin RZ; Galli A
J Neurochem; 2002 May; 81(4):859-69. PubMed ID: 12065645
[TBL] [Abstract][Full Text] [Related]
5. Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake.
Storch A; Hwang YI; Gearhart DA; Beach JW; Neafsey EJ; Collins MA; Schwarz J
J Neurochem; 2004 May; 89(3):685-94. PubMed ID: 15086525
[TBL] [Abstract][Full Text] [Related]
6. Amphetamine regulation of dopamine transport. Combined measurements of transporter currents and transporter imaging support the endocytosis of an active carrier.
Kahlig KM; Javitch JA; Galli A
J Biol Chem; 2004 Mar; 279(10):8966-75. PubMed ID: 14699142
[TBL] [Abstract][Full Text] [Related]
7. Transport-dependent accessibility of a cytoplasmic loop cysteine in the human dopamine transporter.
Chen N; Ferrer JV; Javitch JA; Justice JB
J Biol Chem; 2000 Jan; 275(3):1608-14. PubMed ID: 10636852
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB
Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
[TBL] [Abstract][Full Text] [Related]
9. Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity.
Morón JA; Zakharova I; Ferrer JV; Merrill GA; Hope B; Lafer EM; Lin ZC; Wang JB; Javitch JA; Galli A; Shippenberg TS
J Neurosci; 2003 Sep; 23(24):8480-8. PubMed ID: 13679416
[TBL] [Abstract][Full Text] [Related]
10. Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter.
Whitehead RE; Ferrer JV; Javitch JA; Justice JB
J Neurochem; 2001 Feb; 76(4):1242-51. PubMed ID: 11181843
[TBL] [Abstract][Full Text] [Related]
11. Dopamine prevents nitration of tyrosine hydroxylase by peroxynitrite and nitrogen dioxide: is nitrotyrosine formation an early step in dopamine neuronal damage?
Park S; Geddes TJ; Javitch JA; Kuhn DM
J Biol Chem; 2003 Aug; 278(31):28736-42. PubMed ID: 12771134
[TBL] [Abstract][Full Text] [Related]
12. Modulation of dopamine transporter function by alpha-synuclein is altered by impairment of cell adhesion and by induction of oxidative stress.
Wersinger C; Prou D; Vernier P; Sidhu A
FASEB J; 2003 Nov; 17(14):2151-3. PubMed ID: 12958153
[TBL] [Abstract][Full Text] [Related]
13. Dopamine and norepinephrine transporter-dependent c-Fos production in vitro: relevance to neuroadaptation.
Yatin SM; Miller GM; Madras BK
J Neurosci Methods; 2005 Apr; 143(1):69-78. PubMed ID: 15763138
[TBL] [Abstract][Full Text] [Related]
14. Cocaine alters the accessibility of endogenous cysteines in putative extracellular and intracellular loops of the human dopamine transporter.
Ferrer JV; Javitch JA
Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9238-43. PubMed ID: 9689064
[TBL] [Abstract][Full Text] [Related]
15. Hydrogen peroxide induces loss of dopamine transporter activity: a calcium-dependent oxidative mechanism.
Huang CL; Huang NK; Shyue SK; Chern Y
J Neurochem; 2003 Sep; 86(5):1247-59. PubMed ID: 12911632
[TBL] [Abstract][Full Text] [Related]
16. The role of conserved tryptophan and acidic residues in the human dopamine transporter as characterized by site-directed mutagenesis.
Chen N; Vaughan RA; Reith ME
J Neurochem; 2001 May; 77(4):1116-27. PubMed ID: 11359877
[TBL] [Abstract][Full Text] [Related]
17. Effects of methamphetamine and lobeline on vesicular monoamine and dopamine transporter-mediated dopamine release in a cotransfected model system.
Wilhelm CJ; Johnson RA; Lysko PG; Eshleman AJ; Janowsky A
J Pharmacol Exp Ther; 2004 Sep; 310(3):1142-51. PubMed ID: 15102929
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the lipid-binding domain of alpha-synuclein confer overlapping, yet distinct, functional properties in the regulation of dopamine transporter activity.
Wersinger C; Prou D; Vernier P; Niznik HB; Sidhu A
Mol Cell Neurosci; 2003 Sep; 24(1):91-105. PubMed ID: 14550771
[TBL] [Abstract][Full Text] [Related]
19. Impairment of the neuronal dopamine transporter activity in MPP(+)-treated rat was not prevented by treatments with nitric oxide synthase or poly(ADP-ribose) polymerase inhibitors.
Barc S; Page G; Barrier L; Piriou A; Fauconneau B
Neurosci Lett; 2001 Nov; 314(1-2):82-6. PubMed ID: 11698152
[TBL] [Abstract][Full Text] [Related]
20. Conformational changes in dopamine transporter intracellular regions upon cocaine binding and dopamine translocation.
Dehnes Y; Shan J; Beuming T; Shi L; Weinstein H; Javitch JA
Neurochem Int; 2014 Jul; 73():4-15. PubMed ID: 24576496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]